Ryan Specialty price target lowered to $45 from $52 at Barclays
Barclays lowered the firm’s price target on Ryan Specialty (RYAN) to $45 from $52 and keeps an Overweight rating on the shares. The insurance broker group has “derated sharply on fears of AI-driven disruption,” the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now “more than discount” slower growth while overlooking durability of the broker business model and AI’s potential to support productivity and margins. The analyst views AI as a “productivity enabler” for the brokers.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Read More on RYAN:
- Ryan Specialty price target lowered to $44 from $53 at Mizuho
- Ryan Specialty downgraded to Market Perform from Outperform at BMO Capital
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 22
- Ryan Specialty price target lowered to $65 from $71 at UBS
- Ryan Specialty price target lowered to $45 from $52 at Cantor Fitzgerald
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Toncoin Bridge Shutdown Confirmed: Users Face Deadline to Recover Funds
This Ripple Document States What Determines XRP Price
How Much XRP Will You Sell If It Hits $100 Tomorrow? XRP Army Responds
The first privacy coin ETF: inside Grayscale’s Zcash filing
Trending news
MoreCrypto prices
More
